Kymera launches with $30 million to tackle targeted protein degradation

Backed by Atlas Venture, the firm hopes to put its first compound in the clinic in 2020

» » Kymera launches with $30 million to tackle targeted protein degradation , ago, 34 view
Subscribe to our Facebook Bot

Backed by Atlas Venture, the firm hopes to put its first compound in the clinic in 2020


Read more

2017-10-30T05:11:06Z 250250
Dragplus